Drugs Made In America Acquisition (DMII) EBIT (2025)
Drugs Made In America Acquisition (DMII) reported EBIT of -$235472.0 for Q4 2025, down 51.42% on a QoQ basis from -$155513.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) has 1 years of EBIT data on file, last reported at -$235472.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -427,850.00 |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -482,100.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -201,744.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | -1.15 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -612,993.00 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -218,386.00 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | -198,194.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | -811,301.00 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -168,092.00 |
| 10 | Drugs Made In America Acquisition | 128.97 Mn | 128.97 Mn | - | -235,472.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -235,472.00 |
| Sep 30, 2025 | -155,513.00 |